Sollers College

Tag: career in clinical research

  • What advantages do non-clinical careers offer dentists?

    What advantages do non-clinical careers offer dentists?

    • Many medical professionals find clinical work enjoyable. However, some dentists opt for non-clinical careers to put their medical degrees to use in different ways.
    • There are numerous career options available to medical doctors, in addition to the fact that they treat patients. Non-clinical dental careers are becoming more popular.
    •  An occupation classified as non-clinical is one that does not involve treating or testing patients.
    •  However, these positions still call for the knowledge, training, and experience of medical doctors.
    •  In addition, non-clinical careers act as a transitional step between the dental industry and a corporate career.
    •   For some people who have a connection to the science of medicine, clinical care can be difficult.
    •   After many years of effective practice, seasoned practitioners are eager for a change of scenery and fresh challenges.
    •  However, using qualifications that dentists already have and continuing education after BDS.

    Listed below are a few benefits of applying your medical training to a career outside of medicine:

    1.   Because treating patients can be taxing, some medical professionals are looking for positions that don’t involve the pressures of making evaluations and carrying out life-saving procedures.
    2.   A practicing physician might put in lengthy hours and spend a significant amount of time away from the office while on call for hospital emergencies.
    3.   There are non-clinical careers that offer a better work-life balance.
    4.   Non-clinical careers have good opportunities in the corporate world as well.
    5.   It is impossible to make as much money in a clinical setting as possible by leveraging your pharmaceutical experience.
    6.   Non-clinical careers offer a lot of opportunities. Discovering relevant non-clinical careers in healthcare such as pharmacovigilance, clinical trials, medical transcription, clinical research, medical coding, and medical claim officer.

    Find your area of expertise in healthcare.

    Individuals from different cultural backgrounds shift to non-clinical work by enrolling in certificate programs for a variety of reasons. Still, others might be seeking a change of scenery, while others might find that non-clinical work is a more adaptable option.  Many individuals want to investigate their switching careers. Whatever your reason, working in a variety of non-clinical healthcare positions will allow you to develop the knowledge and abilities you need to pursue a career in healthcare. 

     

  • Why do Dental Students Prefer Drug Safety as a Career

    Why do Dental Students Prefer Drug Safety as a Career

    In today’s world, a dental graduate has a plethora of career options.

    Contrary to popular belief in other fields, transitioning from clinical dentistry to drug safety or pharmacovigilance can be a lucrative career move.

    The curriculum for a dental graduate is not only comprehensive, but it also serves as a foundation for drug safety. Those with a keen interest in Physiology, Pharmacology, Medicine, Oral Medicine, Diagnostics, and other subjects, need not look any further.  

    Dentists play an important role in society as professional health care providers. When playing the role of a Drug Safety Associate, advanced drug safety training will add to their knowledge.

    Many dentists have co-authored clinical research papers and patient reports while under the supervision of subject matter experts at the undergraduate level.

    As observed in various studies, some of the common factors that motivated dental students include 

    1. Attaining financial security 

    2. Becoming an expert professional 

    3. Job satisfaction 

    4. Service to the common man

    This foundational knowledge lays the groundwork for the vast field of clinical research and trials. The knowledge is useful for triage, case processing, review, and analytics.

    Why do Dental Students Prefer Drug Safety as a Career

    A career in drug safety appears to be the appropriate chess move with the shift in medical and dental treatment perspectives. Understanding students’ intentions can aid higher education providers with a complete and accurate picture of the profession.

    A move in the profession as a Drug Safety Associate or a Pharmacovigilance Scientist for a dental graduate could prove important and winning for both sides. 

    Sollers college provides students with the training they need to bridge the gap between their qualifications and the skills required for a career in the pharmaceutical industry. 

    Sollers college provides courses by emphasizing cutting-edge training and certification methods. Empowering professionals with the current market skills results in a trained professional with job-readiness skills and knowledge.

    Our course curriculum, in the pharmaceutical industry, will guide you on your drug safety career path.

    Sollers college provides Advanced Drug Safety courses to meet a variety of training requirements.  Take advantage of the course formats.

    What about a time-bending approach? Looking for advanced training? To read more on this, you have a choice@ Sollers college.

  • Ways to Boost Patient Experience in Clinical Trials

    Ways to Boost Patient Experience in Clinical Trials

    A decade ago, the life sciences sector was junctured to improve patient trust and clinical trial results. Companies have realized that patients and advocates need to sit at the table and center on enterprise models, commercialization, and research and development. It’s a lofty goal to collect as many data points as possible in the shortest amount of time feasible. And how can we recognize the impact that taking part in a clinical study has on the patients we are attempting to help in this way?

    Patients Should Be Walked Through The Clinical Process Frequently And Early

    In most clinical trials, participants don’t think about the additional treatments they’ll be subjected to while selecting whether or not to take part. Is it worth missing several weeks of your life to have therapy that is only available in a few select places? 

    During Study Design, Consider the Patient’s Perspective

    It is very accurate when it comes to creating a positive patient experience. It’s essential to consider the study’s overall goal while deciding what procedures should be included in the protocol, even if many minor details are involved. Even if a surgery isn’t too taxing on its own, the cumulative toll on the patient can be staggering.

    Solicit Patient Input On Your Study Protocol

    Some patients consider clinical trials to help themselves and, more importantly, to help others in the future. As healthcare community members, we can’t take advantage of that desperation. Sponsors must consider the patient a partner in research and the end of their product. In the absence of this step, sponsors risk having a trial that can’t be conducted correctly and, unfortunately, won’t gather the data needed for the proposed study. Our focus must always be on the patients, the driving force behind continuous improvement in the healthcare industry.

    Using technology to reduce the patient burden

    Life sciences companies have to examine their current practices in light of the year 2020’s events and determine how to meet patients’ needs better while also prioritizing patient safety while planning clinical trials. To save their studies, several sponsors have scoured their networks and relationships for methods to collect clinical trial data from problems that are still in progress. It was when technology stepped in.

    When conducting clinical trials remotely or with minimal in-person visits, a clinical trial becomes more patient-centered by design. Clinical investigators and site staff can communicate by teleconference, reducing travel stress on the patient and allowing for a more flexible visit schedule.

    Both researchers and patients benefit from clinical studies. Because these studies are critical, it’s natural to focus on how effective the therapies are when considering their significance. Patients’ experiences in clinical studies are just as meaningful; however, As a patient, what are clinical trials like, and how can healthcare practitioners enhance their experience? Enroll in our certificate program for Clinical Trial Management today. This program is designed to meet the needs of the industrial market.

  • Clinical trial trends and market changes in 2021

    Clinical trial trends and market changes in 2021

    The Covid-19 epidemic created significant logistical issues that trial sponsors had to deal with and address quickly in the previous year, causing a sea change in the clinical trials business. Now that the dust has settled, pharmaceutical firms are confronted with a market that looks quite different from the one they were used to, yet trends they were previously aware of continue to increase in size and prominence.

    Increase in Vaccine Trials

    One of the most pressing global health issues of the last year sparked a race among many pharmaceutical and biotech companies to create a vaccine that may protect against SARS-CoV-2. Over 180 coronavirus vaccines are under preclinical testing, according to the WHO’s Covid-19 Candidate Vaccine Landscape and Tracker. Demand for vaccine trials will continue to be significant. As a result of many vaccination studies, enrollment and start-up times are affected.

    Disruptions to Clinical Trials

    There have been problems with clinical trials in the past. When there was a substantial risk of spreading the disease, clinical studies were forced to suspend enrollment. GlobalData’s Pharma Intelligence Center stated in March 2021 that the Covid-19 epidemic had disrupted more than 1,200 clinical studies worldwide. There were also supply chain issues, including logistical issues related to the provision and transportation of biological samples and supplementary materials for clinical studies, in addition to the point of delayed timeframes.

    Increase in Remote Trials in a Flash

    The conventional clinical trial supply chain saw a dramatic shift as it rapidly adopted the remote trial paradigm. With the help of service providers like Oximio, direct-to-patient techniques solved the logistical issues of distant trials.Clinical trial sponsors can more readily reach a worldwide audience with decentralized studies. Even the most remote locations where patients are situated are included in this. Despite the potential benefits of a more diverse patient population, sponsors must contend with issues related to dynamic customs rules and the shifting tax and regulatory requirements for each region.

    Patients should take personalized medicine.

    Medical genetic profiling is at the heart of personalized medicine, which aims at identifying a treatment that is best suited for each patient by looking at their genetic data. Health care might be transformed by this new trend, which would lead to more tailored studies with higher success rates. For participants, this means that they are more likely to receive effective therapy and do not cause any adverse side effects. On the other hand, sponsors benefit from reduced abandonment rates and more cost-effective studies. Trials focus on a small population of patients and have a considerably smaller number of participants.

    Expansion of Access to and Monitoring after the Trial

    Patients afflicted with severe, life-threatening diseases who are not participating in clinical trials but have no other treatment options can receive experimental therapies through extended access programs. Increasing post-trial duties for sponsors has led to increased demand for post-trial monitoring services.

    What are you waiting for? Sign up for our Clinical Trial Management certificate program today. It is designed to meet the demands of the industrial market.

  • A New Collaboration to Advance Data Sharing in Clinical Research

    A New Collaboration to Advance Data Sharing in Clinical Research

    As clinical research experts, the importance of patient-donated data. Clinical trials may be time-consuming and even burdensome for patients, many organizations are trying to make the best use of their data.

    Although there is a lot of emphasis on integrating real-world data in medication research, clinical trial data is clean, vetted, and of high quality. Historical trial data, in my opinion, are the most valuable untapped resource in our sector.

    Biopharmaceutical firms are beginning to respond to requests from organizations such as the World Health Organization, the National Institutes of Health, the G7, and patient advocacy groups to extensively share patient-donated data. Clinical researchers are eager to make the required adjustments, but we aren’t used to such sharing in non-competitive settings. Furthermore, we may not have the internal resources or mechanisms in place to facilitate data exchange.

    To address these issues, a group of like-minded colleagues from biopharma, contract research companies, technology partners, data sharing platforms, and academic institutions formed the Clinical Research Data Sharing Alliance early this year (CRDSA). CRDSA was established as a collaborative platform for all parties to solve the logistical challenges of exchanging clinical trial data.

    CRDSA will focus on data privacy, data standards, and researcher education to increase both the quantity and value of data provided for secondary research.

    Consider a future in which we can enrol significantly fewer patients in control groups because we have enough secondary data to build a “synthetic” arm. Alternatively, we know ahead of time how many patients from various racial/ethnic groups we need to recruit since we used pooled trial data to predetermine the sub-groups. These future possibilities will necessitate regulatory policy improvements; we must invite regulators along for the ride to decide how synthetic or enhanced control arms can be acceptable for a registrational research. The CRDSA will establish the united, multi stakeholder voice required to effectively advocate for real policy change.

    The public interest is widely regarded as being served by the responsible dissemination of clinical trial data. Data sharing maximises clinical trial participants’ contributions to scientific knowledge, helping patients now and in the future. Sharing clinical trial data can allow for the replication of research findings, analysis for different fields of study, and exploratory work to create new research concepts. While there has been progress in the effort to improve clinical trial data exchange, obstacles persist.

    Upskill yourself with Sollers Clinical Trial Management certification program to meet industrial needs.

  • How Clinical Trial Software is used to Improve Clinical Trials?

    How Clinical Trial Software is used to Improve Clinical Trials?

    Clinical trial software streamlines clinical studies from start to completion. Some examples include protocol management, CRF design, metadata management, and the collection, analysis, and reporting of compliance clinical research data to regulatory authorities.The goal is to deliver high-quality clinical goods to the market as quickly as possible.

    Spreadsheets have traditionally been used to document and manage all elements of clinical studies. That implies a significant chance of mistakes, a lack of crucial data, and bottlenecks in the process. As a result, efficiency, compliance, and patient care have all been jeopardized.

    To keep ahead of rivals, the industry now recognizes that technical cloud-based clinical trial software solutions are critical for faster, more effective clinical trials. In addition, the FDA has advocated for the adoption of cloud-based technology to expedite the clinical trial process.

    Clinical trial software types

    Clinical trial software includes a wide range of software for various phases of the clinical trial process. Among them are the following:

    • CTMS (Clinical Trial Management System) 
    • EDC (Electronic Data Capture System) 
    • Integrated clinical study automation software

    What exactly is a CTMS?

    A clinical trial management system (CTMS) is a cloud-based software platform used to manage clinical studies from start to finish. They are employed in the planning, tracking, and analysis of clinical studies. They assist businesses in improving the quality of their clinical goods, reducing the time it takes to bring a product to market, and ensuring compliance with industry standards and laws. And to locate and manage patients who are willing to participate in clinical studies and track their participation in clinical trials and handle funds.

    CTMS are frequently used with other clinical trial software specializing in a particular area, such as EDCs and integrated clinical study automation software.

    What exactly is an EDC system?

    It is a computerized system that allows users to collect patient data during clinical studies. They usually have a user interface that allows users to enter data into electronic forms. Validation is used to ensure that documents have been filled out correctly. In addition, a reporting tool is provided to allow users to evaluate the acquired data.

    EDCs have been around since the 1990s and are constantly developing. You can target specific patient characteristics or research stages with modern EDCs. Cloud data storage, role-based permissions, CRF designers, clinical data analytics, interactive dashboards, and electronic health record integration are some examples of contemporary features.

    What exactly does integrated clinical trial automation software imply?

    Clinical study automation software is a cloud-based integrated program that focuses on specific aspects of a clinical trial. CRF designers, metadata management, standards governance, data storage, statistical computation, and submission to regulatory agencies are examples of these sorts of systems.

    Where does the industry stand currently in terms of clinical trial software?

    The pharmaceutical sector has been hesitant to experiment with novel techniques and developing IT technologies. Its exclusive concentration has been on bringing clinical medicines to market.

    What are you waiting for? Enroll Now for our Clinical Trial Management certificate program. It is designed in such a way that it will meet the industrial requirements.

  • Future prospects of Pharmacovigilance

    Future prospects of Pharmacovigilance

    Why is Pharmacovigilance required in pharmaceutical markets for all countries? Majorly it is due to adverse drug reactions (ADR) that leads to severe illness, permanent side effects, and even death.

    With rising burden of chronic and non chronic diseases and increase in geriatic population growing pharmaceutical market, no surprise that there is a rapid growth for pharmacovigilance services  in worldwide market. Pharmacovigilance performs a much more pivotal role with the more stringent regulations and the increasing quality of patient centricity than 10 or 20 years ago.

    Current industry trends in pharmacovigilance:

    These days, the evolution of mobile applications, digital health devices, social media set a new standard for patient involvement. Recent statistics illustrate that there is a huge value for social media monitoring and provide valuable information related to drugs. Along with that proactive monitoring helps to give early warnings of new adverse events that helps in drug development and avoid preventable litigation.

    Will the exponential growth of digital health tools become primary for producing high-quality concerns? It stands to reason that proactively observing patient health through digital health materials could provide insight into decreasing the figure and severity of adverse events.

    Social media; Clinical data and electronic health records; Claims files;

    Regulatory reports and filings from different areas;

    ​Secondary data references present unprecedented difficulties in terms of procurement and combination with “classic” data sets. Usage of secondary data by pharmaceuticals is, as of today, just at the initial stage, also considering that it is not required from the regulatory point of view. 

    Recently, technology providers have started giving robust and flexible platforms that support Life Sciences organizations handling and combining multiple file types and including social media streams in their pharmacovigilance methods. Advanced algorithms and disproportionality review are now being developed to accommodate classical automatic reporting and social media streams.

    The secondary data references and advanced signal detection technologies help detect safety risks and take more rapid risk minimization.

    Cloud-based Reporting produces a robust global database of adverse events.

    Many businesses are now profiting from collecting and analyzing vast amounts of data in the cloud. As the amount of data sources grows, Life Sciences companies confront the critical need to optimize the intake, storage, and study of substantial volumes of data.

    The primary reason for transforming to the Cloud is

    Cost and efficiency: Cloud enables organizations to operate with massive data from incidents without yielding security, quality, and data privacy.

    Scalability: The adverse event case workload for Life Science companies has been growing regularly, with some businesses seeing a 50% rise yearly. 

    Simplicity: Cloud usage can simplify the life of companies by empowering them to evade concerns about module adaptability and mounting up servers. Cloud pharmacovigilance is a growing reality. 

    Sollers college provides a Drug Safety & Pharmacovigilance certificate/master’s program for the students/drug safety professionals who want to settle in the healthcare sector.

  • Risks and Benefits of Clinical Trials

    Risks and Benefits of Clinical Trials

    Clinical research has grown to be one of the primary components these days. It is a notable field of study which assists in providing advanced medical treatments and cures.Clinical trials are a necessary study tool for developing medical expertise and patient care.

    This transformation can make it difficult for a patient to want to join in a clinical trial.Researchers don’t know what the consequences of clinical trials will be. Clinical trials are essential for discovering diseases and the latest ways to detect, diagnose, and reduce the disease’s possibility of improving. 

    Clinical trials are conducted to consolidate relevant data to find new drugs for curing or restricting diseases. This data also supports industry and regulators in making meaningful choices about the safety and effectiveness of the disease or preventative medicines being studied. Clinical research project sponsors typically provide critical project constraints such as quality assurance to Contract Research Organizations or CROs.

    What is the Requirement for Quality Assurance (QA) in clinical trials?

    • Quality assurance in clinical trials ensures that globally received Good Clinical Practice (GCP) standards are followed to achieve the tests reasonably and collect high-quality data.
    • CROs help project sponsors with the protocol’s design, project monitoring, report evaluation, and project documentation to be sent to the regulatory authorities for approval.
    •  The clinical research data has to be good enough for verification during audits and inspections by regulatory organizations.
    • The regulations are stringent for clinical research. India has some of the most trusted clinical research duties offering superior quality assurance in clinical trials. 

    What are the Benefits of a Clinical Trial?

    • You may get a new strategy for a disease before it is ready for everyone.
    • You may have the opportunity to support others to get better treatment for their health problems in the future.

    Potential Risks of a Clinical Trial

    • The new medicine may produce severe side consequences or be difficult.
    • The new treatment may not work, or it may not be greater than the standard treatment.
    • You may NOT be part of the practice group that makes the new treatment. 
    • The clinical trial could inconvenience you.

    Along with the numerous advantages, clinical trials also comprise various risks. Let’s have a look at those:

    • It requires more regular visits to the lab than non-clinical trials.
    • Doctors can ask to linger at the hospital for close monitoring.
    • There might be some acute side effects of the trial process that can be life-threatening.
    • The exercise might work for any, but there are indications that it won’t work for a few people.

    Conclusion

    Clinical research in the US is improving with the help of the latest technologies, government facilities, and improved regulations/frameworks. Clinical research has cleared up many productive jobs and business possibilities in Clinical Operations, CDM, Medical writingsPharmacovigilance.

    Proficient professionals are taking a chance to showcase their expertise in research to assist in a better way. Sollers Clinical Trial certificate and Master’s program helps healthcare professionals for their career growth.

  • How to Improve Clinical Trial Recruitment?

    How to Improve Clinical Trial Recruitment?

    Clinical trials are necessary for medical research. Producing new medicines to the market depends on the strength of research organizations and drug companies to test and verify their work vigorously through their Clinical Trials, but finding people willing to participate is notoriously tricky.

    Researchers rely on a constant stream of volunteers to test and validate their outcomes. Recruiting patients for clinical trials is difficult. The latest survey from Clinical Trials Transformation Initiative (CTTI) recorded that protocol-related and clinician-related effects are essential obstacles to recruitment; yet, patient-related blocks also majorly affect the success or failure of clinical enrolment. Limitations include patient perceptions and information about clinical trials, lack of awareness about possibilities to participate in studies, concerns about placebos, travel time, and trial-related expenses.

    Streamline patient testing with the point of care testing devices

    The accumulation of too much data or additional trial methods can lead to more persistent study visits and anticipate streamlining of study design. When addressing the study protocol, firms should recognize the potential influence of selecting medical equipment on patient enrolment and retention.

    Use social media and mobile platforms.

    How patients discover clinical trials has transformed over the years. Before, patients received about practices via media, mail, and their HCPs. Thanks to social media and smartphones, communication is much more direct today. Social media platforms like Twitter and Facebook have made it comparatively easy to recruit patients for clinical trials. Clinical trial sponsors and CROs have nudged up to the power of social media in reaching ‘e-patients.’

    Address patient concerns

    Misunderstandings about clinical trials are amongst the fundamental reasons patients miss chances to be handled within research settings. By building an effort to reach out to patients with available information, companies can dismiss these fears. 

    In producing and managing the trial, study managers should also ensure patients that they will be treated with respect and maintenance at each stage of the study.

    Make the process patient-centric

    The patient recruitment method should depend on individual patients and not diseases. The study design should include the patients’ decisions to ensure the clinical trial has meaningful endpoints. If a clinical trial doesn’t meet real patient requirements, it makes recruitment even more challenging. To make the procurement process patient-centered:

    • Getting feedback from patients about the study design
    • Engaging patients, their peers, and the community as volunteers in the trials
    • Giving input about clinical results
    • Producing research programs
    Improve patient screening methods

    Once patients have been recognized, an efficient screening process needs little travel and is minimally invasive. Thanks to technologies like random sampling, these methods are now possible. They enable applicants to submit their samples from wherever they are without visiting the research facility. 

    Remote reporting

    In recent years, the number and frequency of data points being collected during studies have increased massively. It implies members now coping with complex health requirements are being asked to travel further and attend more.

    But in an environment of instant messaging, wearables, and video calls, there is little demand. Regulatory bodies have accepted this and no longer need 100% on-site monitoring, which can significantly affect a sponsor’s ability to recruit and retain sufficient people to test their product adequately.

    One size doesn’t fit all.

    While companies can use several practical steps to successful patient recruitment limitations, one size does not fit all. Study managers should design an action plan at the start of each trial and ensure they partner with vendors excellently placed to help them achieve their specific goals for the study. The right combination of strategies will provide study managers to tailor their approach, so it works for different patient groups and physicians to enhance patient enrolment and long-term retention.

    Start your path to a career in Clinical Trial Management.The curriculum is focused on enhancing your ability at every stage of the clinical research process.

  • Clinical Trials Changing Face in the Changing World

    Clinical Trials Changing Face in the Changing World

    Technological developments are bringing benefits across the Clinical Development soll life cycles for years. Now, the aspect of Clinical Trial development is even more improved.  In the light of pandemic COVID 19, the field uses new virtual trial technologies to maintain their studies and keep all the patients safe. 

    Innovation and Technology are familiar buzzwords that are common for all industries. But, we are required to remind ourselves that innovative technologies like Clinical Conductor and eTMF are intended to increase the productivity, efficiency, and convenience of a process or activity. It helps to retrieve the trail documents in a timely manner and maintenance of documents for post marketing studies. 

    Challenges in the Pharmaceutical industry:

    • High Clinical trial patient dropout rates
    • Lengthy patient recruitment time
    • Longer study closeouts due to questionable data quality
    • Investigative sites for essential data collection

    Post pandemic has given healthcare professionals new approaches. We have seen the evolution of Artificial Intelligence, the Internet of Medical Things, High precision medical sensors, etc., in the past decade. Now,  it’s easy to see how to include other purpose built-in technologies into clinical development, which can help trial sponsors to boost their clinical development processes. 

    One of the few positives of the pandemic is the limited opportunity to operate differently. All clinical trial stakeholders have been compelled to accommodate and have been surprised by the enduring benefits of virtual trial technologies in many instances. We observe a post-pandemic scenario with more virtual visits, minimizing the need for patients to travel to investigative sites. Increased device integrations with consumer and medical data capture tools, simplifying patients’ participation in clinical trials and improving their overall engagement.  By doing so, the business will profit from more modernized clinical trials, increased patient engagement, and expedited clinical development times.

    Taking all points into consideration, there is no dull day for the aspirants who are in the clinical field. A certification might help to accelerate your career growth in the Healthcare industry. Don’t worry about your educational and professional background. Attend our regular info sessions to get more details.

  • Role of PV & Clinical Trials in Covid-19 Vaccine

    Role of PV & Clinical Trials in Covid-19 Vaccine

    COVID-19 pandemic has generated various challenges and opportunities across the healthcare landscape. The pandemic is shining a flashlight on how these technologies can support organizations quickly and correctly to drive complex administrative provisions, especially in the face of a massive influx of new data treatments for COVID, which are taking place worldwide with the help of Clinical Trials and Pharmacovigilance. 

    The volume and speed of clinical research to discover effective drugs against novel coronavirus has been exceptional. The regulations are made adjustable and convenient without any relaxation in drug safety reporting to address the unmet medical requirements. 

    The pharmacovigilance actions, primarily adverse event reporting despite clinical practice and clinical trials, should continue because patient safety is superior. PV system analyses collect and share drug safety data while aiming to reduce risk to patients in the shortest possible time. PV will apply to both approved drugs and under clinical trials. 

    Biopharmaceutical organizations and health experts are purposefully driving faster and more flexibly than they ever have before. While there is colossal urgency to scale and create these medications quickly, this cannot damage safety and efficacy.

    Owing to the need to produce vaccines quickly during the COVID-19 vaccine research and production, the pharma companies and scientists overcame pharmacovigilance challenges in four major ways without compromising the quality of creating vaccines.

    • Mass Data Collection
    • Regulatory & Safety Reporting
    • Patient Services
    • Mass Manufacturing & Distribution

    Providing the industry with real-time pharmacovigilance data enhances the ability to foretell and respond to safety interests as they happen, not only heightening regulatory compliance but also improving patient safety in both the short- and longer-term. 

    In the longer term, aiding in the business of proactive safety practices will give pharmaceutical companies the competing edge they require to see gaps and possibilities in the life sciences landscape and drive medicine innovation for the world at large.

    With Sollers‘ help, anyone can exceed all the essential tools and technologies. Power your career with Clinical Trial Management and Drug Safety and Pharmacovigilance certification. Sollers College aims to help those who want to begin their career in the healthcare sector; healthcare professionals also accomplish mid-level positions with the certification program’s help.  

  • Trending positions in Clinical Research Field

    Trending positions in Clinical Research Field

    With the advent of industrial advancement, the pharmaceutical sector has grown to its full power and envisioned increasing consistently in the coming years. It means that the demand for skilled human resources is also on the rise. Students are increasingly becoming aware of the healthcare sector’s career aspects and are taking up Life sciences as their major in their studies.

    The technology boom creates more opportunities for clinical research professionals to bring the latest drug therapies from the laboratory to the market. For the one who is excited to climb the career ladder and wants to work in a rewarding healthcare field, this work line is a fantastic opportunity.

    Let’s know what are the top positions in the Clinical Research Field:

    Clinical Research Associate:

    Clinical Research Associate ranked #1 position in this field. The primary responsibility of CRA is to monitor clinical trials. Government research agencies, Pharmaceutical companies, or medical research institutes employ CRA’s.

    Clinical Research Coordinator:

    Clinical research coordinators (CRCs) are accountable for clinical research studies’ daily operations at hospitals, universities, independent medical practices, medical schools, and other research companies and institutions.

    Clinical Research Assistant:

    Clinical Research Assistant monitors clinical trials, takes notes on activities, and ensures compliance with all clinical trial protocols. Enter clinical research data into appropriate fields. Transfer data from paper formats via computer, recorders, or scanners and organize spreadsheets with large numbers.

    To earn a decent salary amount is the dream of every educated individual. Moreover, Life sciences contribute to health care by improving disease resistance by showing the path to develop novel therapeutics and unprecedented medical aids and devices.

    Sollers College aims to help those who want to start their career in healthcare sectors, healthcare professionals can learn more about clinical research and the Clinical trial management process and career up-gradation in today’s environment, including the latest tools and drug research.

  • Why we should pursue a career in Clinical Research

    Why we should pursue a career in Clinical Research

    The Healthcare sector is one of the most lucrative fields across the world. With ever-more high-level technologies obtaining their way onto the marketplace, it is apparent to further examine medicines to how the human body is structured. With eternally more investment going into the clinical research area in the coming years, a career in Clinical research is remarkable and challenging.

    Clinical Trials and Clinical Research are crucial steps in developing new medicines that can safely be utilized and dispensed through GPs, hospitals, and clinics. Not only is it an exciting and diverse job, but it’s also one that is imperative to healthcare systems across the world, and go the extra mile to support.

    Why is Clinical Research a brilliant career?

    Clinical research can distinguish when it comes to saving peoples’ lives or enhancing their quality of life. Not only do clinical trials trial new medicines and drugs for general use, but they also address the diseases that were earlier thought incurable, such as rheumatoid arthritis, heart disease, nervous system disorders, etc.

    You’ll get an opportunity to make a difference in people’s lives, whether through curing patients in new methods or working to resist increasingly-prevalent issues like antibiotic resistance, especially given that no new antibiotics have been discovered over thirty years.

    We can now see the practices that can stave off blindness and improve people’s quality of life from deadly muscle-wasting diseases. Clinical research professionals are responsible for discovering how safe devices, effective drugs, and diagnostic products are, and as such, it’s a demanding role with lots of responsibility riding on it.

    There’s nevermore a cloudy day when you’re seeking a career in clinical research. This sector is ideal if you like to be challenged apart from monitoring, setting up, and closing clinical studies; you’ll also be traveling to several writing reports, research areas, etc. as part of the trials or various organizations.

    Clinical research is an outstanding career to get entangled in if you want to develop your role and push yourself- and at Sollers, that’s something we take too solemnly. Now it’s a great chance to be becoming involved in the opportunities and expanding a variety of trials opening up within the industry. Our dedication to nurturing passionate researchers is a requisite continuous source from helping new talent to developing employees in their existing roles.

    We invest effort and time to make sure that anybody who goes into clinical research is supported and can develop throughout their careers. Our Clinical Research certification can also unlock doors into various jobs and industries, from Project Management to Clinical Operations. It’s what you make of it.

×